Blogs_News_Shenzhen Aivd Biotechnology Co., LTD.

02-03 

New Biomarker for Predicting Lung Cancer Discovered

Chinese scientists identify chimeric autosomal variants in blood that are expected to serve as a novel class of markers to predict lung cancer risk

01-16 

How Rapid Testing Can Help Quickly Identify Influenza

It's important to understand the risk that the flu poses and how to best prepare yourself and your family for the coming season.

12-23 

How Rapid Testing Can Help Quickly Identify COVID-19

As we enter the third cold and flu season since the start of the pandemic, we know that COVID-19 is here to stay. Now that we are coexisting with the disease, we’ve learned that while some safety practices continue to evolve, others have stayed the same.

12-08 

A List of Essentials for Keeping Holiday Travel Merry and Bright

Whether you’re a last-minute packer, an overpacker, a jetsetter, or a roadtripper, how can you edit your travel plans to keep cheer in tact? Here’s what you need.

12-07 

Breaking News about SARS-CoV-2 from NATURE

If the ACE2 receptor is turned off, wouldn't that prevent all variants?

12-05 

Catch The Match, Not A Virus

As soccer fans unite, testing can help keep gatherings across the world stay safe.

12-02 

Three Tips to Prepare for the Tripledemic Season of COVID-19, Flu and RSV Viruses

What can you do to protect yourself and your loved ones during this viral season? Here are some tips to guide you through the COVID-19, flu and RSV season.

12-01 

Genome-wide reconstruction technology helps to predict embryonic disease risk

Preimplantation genetic testing (PGT) refers to the screening of embryonic chromosomes before embryo implantation to exclude embryos carrying genetic diseases and chromosomal abnormalities to effectively reduce birth defects and is one of the most valuable tools in assisted reproductive technologies to improve pregnancy success rates. However, due to the limited genetic material in embryos and the imprecision associated with allelic deletions, a comprehensive analysis of the embryo genome is costly and time-consuming.

11-24 

Synthetic biomarkers: a new way of early cancer detection

Early detection of cancer while it is still localized can improve the response to medical intervention for patients with most cancer types. The success of screening tools such as cervical cytology in reducing mortality has sparked great interest in new methods for early detection (e.g., using noninvasive blood or biofluidic biomarkers). However, biomarkers generated from early lesions are limited by fundamental biological and transport barriers, such as short circulation times and dilution in the blood, requiring highly sensitive methods to detect very low signal levels. In addition, individual biomarkers often lack specificity, and they may be elevated in non-cancerous conditions or present in multiple cancers, which requires the identification of multiple combinations of analytes to assess disease.

11-10 

Introduction to the tests that can be carried out in PCR laboratories

Driven by the policy and the epidemic, many medical institutions around the world have established independent and compliant PCR laboratories. In addition to neo-crown nucleic acid testing, what else can PCR laboratories do? The following is a compilation of the tests that can be carried out in PCR laboratories.

GICA

FIA

CLIA

ELISA

Latex

TIA

Molecular Diagnostics

Calibrators

Others

COVID-19

Infectious diseases

Cardiac diseases

Tumor

Inflammation

Diabetes

Tropical diseases

Primary & Secondary antibodies

Renal function

Anemia

Thyroid function

Respiratory diseases

Gastrointestinal disease

Liver disease

Blockers

Calibrator

Other diseases